ECOG-ACRIN EA6174 (Merkel Cell Carcinoma) - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
Adults with Merkel cell carcinoma (MCC).
What is Involved?
If you choose to join the study you will:
-Either get the study drug, Pembrolizumab, after surgery, OR
-Be observed after surgery for up to 1 year (no study drug)
-Complete regular follow-up appointments with your doctor every 6 months for 5 years